News Politics
#Nestle buys peanut allergy treatment maker
by NewsNews
Nestle will pay $2 billion to buy the remaining stake in Aimmune Therapeutics Inc, gaining full ownership of the first U.S.-approved peanut allergy treatment.
- Duration: 00:59
Share
Keywords
- Coronavirus: Reveal what plasma treatment consists of03:40
FreshNews - News - Mylan cuts patient cost of EpiPen00:50
worldNews24 - Mom tries to save time and buys a tortilla maker at the swap meet.00:46
RayMilthony - Hyperhidrosis Treatment02:23
hyperhidrosismd - RAW - Meet Peanut the 'Ewe-nicorn'01:00
RayMilthony - Semen Allergy?05:00
MetatubeSpecials - Coronavirus Treatment Tested00:49
CNNews